Anti-Human SHP2 (CT)

Leinco Technologies
Product Code: LEI-S519
Product Group: Primary Antibodies
CodeSizePrice
LEI-S519-20ug20 ug£199.00
Quantity:
LEI-S519-0.1mg0.1 mg£591.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Application: Western Blot (WB)
Shipping:
Ambient
Storage:
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage aliquot in working volumes without diluting and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.

Images

1 / 1

Further Information

Concentration:
0.5 mg/ml
Conjugate/Tag/Label:
Purified No Carrier Protein
Format:
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Formulation:
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Immunogen:
PN:S526
Long Description:
Src homology-2 domain containing protein (SHP2) is a member of the protein tyrosine phosphatase (PTP) family, a protein family that contains signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. SHP2 contains two tandem Src homology-2 (SH2) domains, which function as phosphotyrosine binding domains either directly or through scaffolding intermediates such as the insulin-receptor substrate 1 (IRS-1). These SH2 domains mediate the interaction of SHP2 with its substrates, allowing SHP2 to dephosphorylate proteins that inhibit signaling kinases such as ERK1 and AKT. SHP2 is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Recent experiments have shown SHP2 plays a significant role in hepatoprotection and liver regeneration.
Target:
SHP2

References

1. Yu, Z. et al. (1997) J. Biol. Chem. 272:7519 2. Ostman, A. et al. (2006) Nat. Rev. Cancer 6:307 3. Bard-Chapeau, EA. et al. (2006) Mol. Cell. Biol. 26:4664

Related Products

Product NameProduct CodeSupplier 
Anti-Human SHP2 (NT)LEI-S520Leinco Technologies Summary Details
SHP2 (CT) Blocking PeptideLEI-S526Leinco Technologies Summary Details
SHP2 (NT) Blocking PeptideLEI-S527Leinco Technologies Summary Details